Investment Rating - The report maintains a "Strong Buy" rating for the company, indicating an expectation to outperform the benchmark index by over 20% in the next six months [4][17]. Core Insights - The company demonstrated impressive performance in the first half of 2025, with revenue increasing by 31.3% year-on-year to 2.59 billion and net profit rising by 36.1% to 670 million, aligning with market expectations [1][9]. - The company is expanding its product categories, particularly in the fragrance segment, and has successfully launched high-end perfume series, enhancing its brand positioning [9]. - The dual-channel strategy (online and offline) is showing robust growth, with online sales increasing by 39% and offline sales by 27%, indicating a healthy synergy between the two channels [9]. Financial Performance Summary - Revenue projections for the upcoming years are as follows: 2024A at 3.885 billion, 2025E at 5.142 billion, 2026E at 6.588 billion, and 2027E at 8.273 billion, with respective growth rates of 34.6%, 32.4%, 28.1%, and 25.6% [3][11]. - The net profit is expected to grow from 881 million in 2024A to 1.936 billion in 2027E, with growth rates of 33.0%, 35.3%, 28.2%, and 26.8% [3][11]. - The company maintains a strong gross margin of 84.2% and a net margin of 25.9% in the first half of 2025, reflecting stable profitability [9]. Business Segmentation - Revenue breakdown shows 55% from color cosmetics, 42% from skincare, 3% from makeup artistry training, and 0.4% from fragrances [9]. - The offline sales contribute 47% of total revenue, while online sales account for 50%, showcasing a balanced distribution between channels [9]. Future Growth Potential - The company has significant room for SKU expansion, currently at approximately 400 SKUs, particularly in lip, eye, and foundation products [9]. - The report highlights the potential for improved store efficiency compared to international brands, suggesting ongoing growth opportunities [9].

Investment Rating - The report maintains a "Buy" rating for the company [5] Core Insights - The company’s PD-L1 small molecule inhibitor ABSK043 has received approval for clinical research to treat KRAS G12C mutated NSCLC in combination with the KRAS G12C inhibitor, adagrasib [1] - ABSK043 shows potential as a first-in-class (FIC) oral PD-L1 inhibitor, with no other oral PD-(L)1 drugs currently available globally [2] - The initial clinical data indicates a balance of efficacy and safety, with 87% of patients experiencing treatment-emergent adverse events (TEAEs) and no peripheral neuropathy observed [2] - ABSK043 is designed specifically for combination therapy, offering advantages such as a short half-life, reduced immunogenicity, and oral administration flexibility [3] - The market potential for ABSK043 is significant, targeting approximately 45%-60% of NSCLC cases, with ongoing clinical trials in various treatment settings [3] Financial Projections - The company is projected to achieve revenues of 630 million, 685 million, and 637 million yuan for the years 2025, 2026, and 2027 respectively [5] - Expected net profits for the same period are 45 million, 70 million, and 102 million yuan [5] - The target price for the stock is set at 22.88 HKD, with the current price at 19.62 HKD [5] Pipeline Developments - The company has several key assets nearing milestones, including: 1. KRAS-G12D inhibitor ABSK141, expected to receive IND approval in the second half of 2025 [4] 2. Pan-KRAS inhibitor ABSK211, anticipated to enter clinical stages in 2026 [4] 3. CSF-1R inhibitor ABSK021, with an NDA submission planned for the second half of 2025 [4] 4. A bispecific antibody-drug conjugate (BsADC) targeting two pan-cancer targets, expected to achieve preclinical candidate status in early 2026 [4]

Investment Rating - The report assigns an "Accumulate" rating for the company, marking its first coverage [1]. Core Insights - The company, Tehai International, serves as the overseas listing platform for Haidilao, leading the expansion of Chinese cuisine internationally. It aims to enhance its global store layout and accelerate the internationalization of Chinese dining [6][11]. - The overseas hot pot market is projected to reach a scale of $30 billion, supported by over 60 million overseas Chinese, with local consumers also contributing to brand expansion [6][41]. - Tehai International is positioned as the largest Chinese dining brand in international markets, leveraging its strong brand presence and operational capabilities [6][47]. Summary by Sections Company Overview - Tehai International operates as the overseas platform for Haidilao, with 122 stores globally as of 2024, focusing on direct operations and local product offerings [11][12]. - The company has achieved significant revenue growth, with a projected revenue of $778.31 million in 2024, reflecting a year-on-year increase of 13.07% [1][6]. Industry Overview - The report highlights that the internationalization of Chinese cuisine is timely, with Tehai International being a key player in this trend. The company is expected to benefit from the growing acceptance of hot pot among local consumers [6][37]. - The international Chinese dining market is characterized by low concentration, providing opportunities for growth, especially for standardized offerings like hot pot [6][45]. Competitive Advantages - Tehai International is recognized as the leading hot pot brand, with a robust operational framework and supply chain management that supports its international expansion [6][56]. - The company has optimized its store model, reducing the average return period to 5.1 years, and is enhancing customer engagement through localized services and cultural events [6][31]. Financial Analysis - The financial projections indicate a compound annual growth rate (CAGR) of 50.6% for net profit from 2025 to 2027, with expected profits of $49.45 million in 2025 [1][6]. - The report anticipates a steady increase in the number of overseas stores, reaching 149 by 2027, further solidifying the company's market position [6][11].

Investment Rating - The investment rating for Kuaishou-W (01024.HK) is "Outperform the Market" (maintained) [2][7]. Core Insights - OpenAI's release of the Sora 2 video generation model and the Sora App is expected to accelerate the demand for AI-generated content (AIGC) [3][6]. - Sora 2 features significant advancements in image resolution, style control, and instruction adherence, integrating audio-video synchronization technology to enhance physical simulation accuracy [4]. - The Sora App, designed similarly to TikTok, allows users to create AI-generated videos up to 10 seconds long and includes a "Cameo" feature for digital avatars, which could create new monetization opportunities for IP holders [5][6]. Financial Forecast and Valuation - The projected financials for Kuaishou include: - Revenue growth from CNY 660.26 billion in 2024 to CNY 865.93 billion in 2027, reflecting an annual growth rate of approximately 8% to 11% [19]. - Net profit is expected to increase from CNY 194.07 billion in 2024 to CNY 268.42 billion in 2027, with a net profit growth rate of 8% to 18% [19]. - The adjusted EPS is forecasted to rise from CNY 24.15 in 2024 to CNY 34.12 in 2027 [19]. - Key financial ratios include: - ROE is projected to decrease from 20% in 2024 to 17% in 2027 [19]. - The gross margin is expected to improve from 53% in 2024 to 58% in 2027 [19].

Investment Rating - The investment rating for Kuaishou-W (01024.HK) is "Outperform the Market" (maintained) [2][7]. Core Insights - OpenAI's release of the Sora 2 video generation model and the Sora App is expected to significantly boost the demand for AI-generated content, creating new opportunities in the social media landscape [3][6]. - Sora 2 features advancements in image resolution, style control, and instruction adherence, integrating audio-visual synchronization to enhance realism in generated videos [4][5]. - The Sora App, designed similarly to TikTok, allows users to create and share AI-generated videos, fostering a new social ecosystem around AI content creation [5][6]. Summary by Sections Company Overview - Kuaishou is positioned as a leader in the AI video sector, with its AI-generated video capabilities showing strong performance and continuous improvement [6]. Market Dynamics - The introduction of Sora 2 is anticipated to reshape the short video ecosystem, potentially increasing the proportion of AI-generated content and narrowing the gap with platforms like Douyin [6]. Financial Projections - The financial outlook includes projected revenues of 660,257 million in 2024, increasing to 865,930 million by 2027, with a net profit growth rate of 68% in 2024 [19].

Investment Rating - The report upgrades the investment rating to "Buy" based on the smooth commercialization process of the company's core product [6] Core Insights - The company's core product, SKB264, has been recognized for its potential in treating EGFR mutation NSCLC, with two key clinical studies selected for presentation at the 2025 ESMO conference, highlighting its significance in the field [1][2] - SKB264 has received approval for 3L treatment of EGFR mutation NSCLC in mainland China and is making progress in earlier lines of treatment, with a 2L NSCLC indication submission accepted for priority review [2] - The clinical trial results for SKB264 show significant improvements in progression-free survival (PFS) compared to existing treatments, indicating its competitive edge in the market [2][4] - SKB264 demonstrates efficacy in treating rare EGFR mutations, providing new treatment options for patients lacking standard therapies [3] - The product has also shown promise in breast cancer treatment, with recent approvals and ongoing clinical trials indicating its potential in HR+/HER2- breast cancer [4][5] Financial Projections - Revenue projections for the company are estimated at 2.084 billion, 2.876 billion, and 4.663 billion yuan for the years 2025, 2026, and 2027 respectively, with net profits expected to improve significantly by 2027 [6]

Investment Rating - The report maintains a "Buy" investment rating for the company [5] Core Insights - The company, Zhouliufu, is a leading brand in the gold and jewelry industry, with a focus on both online and offline channels for growth [1][3] - The Chinese jewelry market is expected to grow from 728 billion yuan in 2024 to 937 billion yuan by 2029, with gold jewelry maintaining a dominant position [2][32] - The company has a total of 3,857 stores as of mid-2025, ranking fifth in the country, and is expanding its presence in high-end markets while optimizing its store model [3][4] Summary by Sections Company Overview - Zhouliufu was founded in 2004 and has established a strong presence in the gold and jewelry sector, focusing on cost-effective products for the lower-tier markets [17] - The company operates primarily through a franchise model, which has facilitated rapid expansion, with 3,857 stores nationwide by mid-2025 [17][25] Industry Analysis - The jewelry market in China is expanding, driven by consumer demand for gold, which accounted for 73% of the market retail sales value in 2024 [32][34] - The market is characterized by low concentration, with the top five brands holding a combined market share of 41% in gold jewelry [36] Business Model and Strategy - Zhouliufu leverages a dual-channel strategy, with significant growth in online sales, which accounted for 53% of total revenue by mid-2025 [25][45] - The company is focusing on product diversification and targeting young female consumers, with 80% of online users being women aged 18-35 [57] Financial Performance - The company forecasts steady revenue growth, with projected revenues of 64.11 billion yuan in 2025, reflecting a year-on-year increase of 12.11% [11] - The earnings per share (EPS) for 2025 is estimated at 1.82 yuan, with a price-to-earnings (PE) ratio of 23 times [4][11] Market Position - Zhouliufu's market strategy includes expanding into high-end markets while maintaining a strong foothold in lower-tier cities, with a significant number of stores in these areas [50] - The company is actively enhancing its brand image through various marketing initiatives and collaborations, aiming to strengthen its market position [55][56]

Investment Rating - The report suggests a cautious subscription for the company, Yunji Technology (2670.HK) [1][4]. Core Insights - The company is a leading AI-enabled robotics service provider, offering adaptable and scalable products and services, including robots and AI digital systems [2]. - In 2024, the company is expected to have an average of 27,000 concurrently online robots, serving 230 million consumers, ranking first globally in the three-dimensional multi-layer space robotics market [2]. - The global intelligent agent market is projected to grow from RMB 39 billion in 2020 to RMB 94.6 billion in 2024, with a compound annual growth rate (CAGR) of 44.8% from 2024 to 2029 [3]. - The company's total revenue for 2022, 2023, and 2024 is projected to be RMB 161.3 million, RMB 145.2 million, and RMB 244.8 million, respectively, indicating an improvement in commercial viability and sustainable growth potential [4]. Summary by Sections IPO Details - The IPO price is set at HKD 95.6 per share, with a total fundraising amount of HKD 590 million [1]. - The total number of shares available for subscription is 6.9 million, with 95% allocated for international placement and 5% for public offering [1]. Market Overview - The market for physical robot forms of intelligent agents is expected to grow from RMB 37.8 billion in 2020 to RMB 82 billion in 2024, with a CAGR of 21.3% [3]. - The market for non-physical robot forms is projected to increase significantly, from RMB 1.2 billion in 2020 to RMB 12.69 billion in 2029, with a CAGR of 58.7% from 2024 to 2029 [3]. Financial Performance - The company's net losses for 2022, 2023, and 2024 are projected to be RMB 365.4 million, RMB 264.5 million, and RMB 185 million, respectively, indicating a trend towards improved financial health [4]. - The company's valuation based on the IPO price corresponds to a price-to-sales (PS) ratio of 24.5 times for 2024, which is considered reasonable relative to the industry average [4].

Investment Rating - The investment rating for the company is "Outperform the Market" [5][20]. Core Insights - The company's revenue for the first half of 2025 remained stable at 6.644 billion, with a year-on-year decline in net profit attributable to shareholders of 9.0% [1][7]. - The medical device segment showed stable pricing, while the pharmaceutical packaging segment saw a significant increase in overseas sales, with the "ship-to-ship" sales ratio rising to 35%, an increase of nearly 10 percentage points year-on-year [2][10]. - The company has established a multi-dimensional barrier with brand image, quality control, scale effect, and cost advantages, indicating strong growth potential and industry leadership [20]. Revenue and Profitability - The company's revenue for the first half of 2025 was 66.44 billion (+0.1%), while the net profit attributable to shareholders was 10.08 billion (-9.0%), with a 12.7% decline after excluding one-time impacts [1][7]. - The gross profit margin decreased to 49.7% (down 1.2 percentage points year-on-year), reflecting pricing pressures on products [3][14]. - The net profit margin fell to 15.9% (down 1.5 percentage points year-on-year) [3][14]. Segment Performance - The medical device business generated approximately 33.0 billion in revenue, remaining stable year-on-year, but the segment profit decreased by 17.1% due to price declines and foreign exchange losses [2][10]. - The orthopedic business revenue was 7.3 billion (-1.6%), primarily due to a change in sales model for joint products, leading to lower factory prices [11]. - The interventional business revenue was 9.9 billion (-2%), with growth in the U.S., Europe, Middle East, and Africa regions [11]. Financial Forecasts - The revenue forecasts for 2025-2027 are adjusted to 137.6 billion, 148.5 billion, and 159.6 billion, with year-on-year growth rates of 5.1%, 8.0%, and 7.4% respectively [20]. - The net profit forecasts for the same period are 21.2 billion, 24.0 billion, and 26.8 billion, with year-on-year growth rates of 2.3%, 13.4%, and 11.6% respectively [20]. Cash Flow and Dividends - The operating cash flow for the first half of 2025 was 8.82 billion, with a cash content of net profit reaching 87%, indicating a healthy cash flow position [18]. - The board proposed a dividend of 4.42 billion for the first half of the year, maintaining a 50% payout ratio based on operating net profit [1][7].

Investment Rating - The report initiates coverage with a "Buy" rating for the company [8][3]. Core Insights - The report emphasizes the "Content + Platform" flywheel effect, highlighting the growth potential of the TapTap platform and the company's self-developed games [7][10]. - The company is expected to achieve significant revenue growth, with projected revenues of 64.31 billion, 79.27 billion, and 90.59 billion RMB for 2025-2027, representing year-on-year growth rates of 28%, 23%, and 14% respectively [8][3]. - Adjusted net profits are forecasted to be 17.02 billion, 22.26 billion, and 27.60 billion RMB for the same period, with growth rates of 94%, 31%, and 24% respectively [8][3]. Financial Data and Profit Forecast - Revenue projections for the company are as follows: - 2023: 3,389 million RMB - 2024: 5,012 million RMB - 2025E: 6,431 million RMB - 2026E: 7,927 million RMB - 2027E: 9,059 million RMB - Year-on-year growth rates for revenue are projected at -1%, 48%, 28%, 23%, and 14% respectively [6]. - Adjusted net profit forecasts are: - 2023: -34 million RMB - 2024: 877 million RMB - 2025E: 1,702 million RMB - 2026E: 2,226 million RMB - 2027E: 2,760 million RMB - Year-on-year growth rates for net profit are projected at 93%, 2670%, 94%, 31%, and 24% respectively [6]. Market Dynamics - The gaming industry is experiencing a recovery in license issuance, with a total of 1,195 licenses issued in the first nine months of 2025, a year-on-year increase of 25% [11][31]. - The report notes that TapTap is becoming an increasingly important channel for game promotion, with its online promotion service revenue reaching 976 million RMB in the first half of 2025, capturing approximately 3.27% of the mobile game advertising market [7][23]. - The growth of TapTap is driven by improvements in domestic licensing, advancements in self-developed games, and strategic expansions into PC and international markets [11][30]. Competitive Advantage - TapTap's low revenue-sharing model (maximum 5% for paid games and free-to-play games incur no fees) is highlighted as a significant advantage for attracting developers, especially independent and small developers [25][10]. - The platform has established a strong community and content ecosystem, differentiating itself from traditional app stores and social media platforms [10][25]. - The report suggests that the market has not fully recognized the value and potential of the TapTap platform, which is well-positioned to capitalize on the evolving gaming landscape [10][11].